Literature DB >> 20083094

The association between transforming growth factor beta3 polymorphisms and left ventricular structure in hypertensive subjects.

Bang-Chuan Hu1, Li Li, Ren-Hua Sun, Ping-Jin Gao, Ding-Liang Zhu, Ji-Guang Wang, Shao-Li Chu.   

Abstract

BACKGROUND: Transforming growth factor beta (TGF-beta) may be a crucial regulator of cardiac remodeling. We investigated the association between the TGF-beta gene polymorphisms and left ventricular structure.
METHODS: A total of 658 hypertensive subjects were genotyped for the TGF-beta1 T869C and TGF-beta3 (rs3917187 and rs4252338) polymorphisms.
RESULTS: TGF-beta3 rs3917187 AA homozygotes had, while accounting for covariates, greater left ventricular end-systolic (LVESD, P=0.004) and end-diastolic dimension (LVEDD, P=0.007) than G allele carriers. Moreover, left ventricular mass index (LVMI) in AA genotype was 123.0+/-3.1g/m(2) significantly higher than that in AG (114.6+/-1.6g/m(2)) and GG (115.4+/-2.1g/m(2), P=0.03) genotypes. In multivariate regression analysis, TGF-beta3 rs3917187 genotype as an independent predictor had statistically significant effects on LVESD (beta=0.164, P=0.002), LVEDD (beta=0.172, P=0.003) and LVMI (beta=0.136, P=0.016), respectively. In further analyses, we observed a significant interaction between the rs3917187 and alcohol intake in relation to LVESD (P(int)=0.04) and left ventricular fractional shortening (LVFSH, P(int)=0.012). However, no relationship could be found between left ventricular parameters and the T869C or the rs4252338.
CONCLUSION: The present results demonstrated that the TGF-beta3 rs3917187 polymorphism was associated with left ventricular structure, and had an interactive influence with alcohol on LVESD and LVFSH in hypertensive subjects. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20083094     DOI: 10.1016/j.cca.2010.01.014

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

Review 1.  Transforming growth factor beta signaling in adult cardiovascular diseases and repair.

Authors:  Thomas Doetschman; Joey V Barnett; Raymond B Runyan; Todd D Camenisch; Ronald L Heimark; Henk L Granzier; Simon J Conway; Mohamad Azhar
Journal:  Cell Tissue Res       Date:  2011-09-28       Impact factor: 5.249

2.  Transforming growth factor-β3 (TGF-β3) knock-in ameliorates inflammation due to TGF-β1 deficiency while promoting glucose tolerance.

Authors:  Bradford E Hall; Umesh D Wankhade; Joanne E Konkel; Karthik Cherukuri; Chandrasekharam N Nagineni; Kathleen C Flanders; Praveen R Arany; Wanjun Chen; Sushil G Rane; Ashok B Kulkarni
Journal:  J Biol Chem       Date:  2013-09-20       Impact factor: 5.157

3.  Phenotype-Specific Association of Single-Nucleotide Polymorphisms with Heart Failure and Preserved Ejection Fraction: a Genome-Wide Association Analysis of the Cardiovascular Health Study.

Authors:  David P Kao; Laura M Stevens; Michael A Hinterberg; Carsten Görg
Journal:  J Cardiovasc Transl Res       Date:  2017-01-19       Impact factor: 4.132

4.  Generation of mice with a conditional allele for the transforming growth factor beta3 gene.

Authors:  Thomas Doetschman; Teodora Georgieva; Hongqi Li; Thomas D Reed; Christina Grisham; Jacqueline Friel; Mark A Estabrook; Connie Gard; L P Sanford; Mohamad Azhar
Journal:  Genesis       Date:  2012-01-06       Impact factor: 2.487

5.  A follow-up study for left ventricular mass on chromosome 12p11 identifies potential candidate genes.

Authors:  David Della-Morte; Ashley Beecham; Tatjana Rundek; Liyong Wang; Mark S McClendon; Susan Slifer; Susan H Blanton; Marco R Di Tullio; Ralph L Sacco
Journal:  BMC Med Genet       Date:  2011-07-26       Impact factor: 2.103

6.  TGFβ3 (TGFB3) polymorphism is associated with male infertility.

Authors:  Marek Droździk; Maciej Kaczmarek; Damian Malinowski; Urszula Broś; Anna Kazienko; Rafał Kurzawa; Mateusz Kurzawski
Journal:  Sci Rep       Date:  2015-11-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.